
- After a randomized trial showed no clinical benefit of mitral valve repair among patients with chronic, moderate ischemic MR undergoing coronary artery bypass grafting, the LOE was changed from C (consensus) to B-R (moderate quality evidence from ≥1 randomized controlled trial [RCT] or meta-analyses of moderate-quality RCT) for the Class IIb recommendation for mitral valve repair in this population.
É emocionante ouvir um cirurgião cardíaco descrever o reparo da valva Mitral .
Parece mágico.
Mas não é.
.
Descubra mais sobre EchoTalk Echocardiography
Assine para receber nossas notícias mais recentes por e-mail.